#WarningLetters hashtag - Bluesky

@pharmaphorum.bsky.social

3 weeks ago

In a move that will delight #NovoNordisk and #EliLilly, the #FDA has sent #warningletters to 30 #telehealth companies, accusing them of #illegallymarketing #compounded #GLP1 agonist formulations.

buff.ly/GbfCB89

0 0 0 0

Compliance Architects

@comparchitects.bsky.social

3 months ago

What can recent FDA Warning Letters teach us?

From recurring GCP failures to sponsor oversight gaps—2024–2025 enforcement actions reveal clear risks.

We break down the patterns and share proactive strategies to stay inspection-ready.
compliancearchitects.com/re...

#WarningLetters #ClinicalTrials

0 0 0 0

Compliance Architects

@comparchitects.bsky.social

5 months ago

What can recent FDA Warning Letters teach us?

From recurring GCP failures to sponsor oversight gaps—2024–2025 enforcement actions reveal clear risks.

We break down the patterns and share proactive strategies to stay inspection-ready.
compliancearchitects.com/re...

#WarningLetters #ClinicalTrials

0 0 0 0

Compliance Architects

@comparchitects.bsky.social

6 months ago

What can recent FDA Warning Letters teach us?

From recurring GCP failures to sponsor oversight gaps—2024–2025 enforcement actions reveal clear risks.

We break down the patterns and share proactive strategies to stay inspection-ready.
compliancearchitects.com/re...

#WarningLetters #ClinicalTrials

0 0 0 0

Compliance Architects

@comparchitects.bsky.social

9 months ago

What can recent FDA Warning Letters teach us?

From recurring GCP failures to sponsor oversight gaps—2024–2025 enforcement actions reveal clear risks.

We break down the patterns and share proactive strategies to stay inspection-ready.
compliancearchitects.com/re...

#WarningLetters #ClinicalTrials

0 0 0 0

Melayna

@melaynalokosky.bsky.social

1 year ago

Musk's Neuralink should have already had several #WarningLetters from FDA over Neuralink False Safety & Advertising claims.

0 0 0 0